Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion

Leukemia - United Kingdom
doi 10.1038/sj.leu.2405029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

JAMA Oncology
Cancer ResearchOncology
2018English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Impacts of Post-Transplantation Cyclophosphamide Treatment After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia Harboring T(7;11)(p15;p15)

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Late Ovarian and Intestinal Extramedullary Relapse of Acute Myeloid Leukemia With Inv 16 After Allogeneic Hematopoietic Stem Cell Transplantation

Annals of Hematology & Oncology
2018English

Preliminary Results of the Safety of Immunotherapy With Gemtuzumab Ozogamicin Following Reduced Intensity Allogeneic Stem Cell Transplant in Children With CD33+ Acute Myeloid Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy